Biobanks

See the following -

Lab Informatics Market worth 2.97 Billion USD by 2021

Press Release | MarketsandMarkets | December 7, 2016

The report "Lab Informatics Market by Product (CDS, EDC, LES, ECM, ELN, LIMS, SDMS), Component (Software, Services), Delivery (On-Premise, Hosted, Cloud) & Industry (CROs, Pharma, Biotechnology, Chemical, Petrochemical, F&B, Agriculture, Oil, Gas) - Forecasts to 2021", The global laboratory informatics market is expected to reach USD 2.97 Billion by 2021 from an estimated value of USD 2.20 Billion in 2016, growing at a CAGR of 6.2% during the forecast period...

Read More »

OpenSpecimen Streamlines Management of Biospecimen Data

OpenSpecimen is an open source biobanking informatics platform that permits users to enter and retrieve data concerning the collection, storage, quality assurance, and distribution of biospecimens. Its most important feature is the ability to collect high-quality, standards-based data specific to a disease or set of study requirements. OpenSpecimen, previously known as caTissue, was initially developed with U.S. National Cancer Institute funding under the caBIG program. When the caBIG program closed down in 2011, Krishagni Solutions continued the development and support of caTissue while maintaining the open source nature of the product. In 2014, Krishagni renamed the product to OpenSpecimen to indicate that the product can support any disease (i.e. not just cancer) and any specimen type (i.e. not just tissue)...

Read More »